MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b.
Roscigno G, Quintavalle C, Donnarumma E, Puoti I, Diaz-Lagares A, Iaboni M, Fiore D, Russo V, Todaro M, Romano G, Thomas R, Cortino G, Gaggianesi M, Esteller M, Croce CM, Condorelli G.
Roscigno G, et al. Among authors: russo v.
Oncotarget. 2016 Jan 5;7(1):580-92. doi: 10.18632/oncotarget.5979.
Oncotarget. 2016.
PMID: 26556862
Free PMC article.